Business Context and Reporting Period
This Form 8-K was filed by Chicago Mercantile Exchange Holdings Inc. on September 20, 2005. The report details a material definitive agreement entered into on the same date between CME (a wholly owned subsidiary) and Standard & Poor's (S&P), a division of The McGraw-Hill Companies, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The agreement involves a per trade fee payable by CME to S&P in exchange for licensing rights, but no aggregate financial figures are disclosed in this document.
Material Changes and Agreement Terms
- Agreement Type: Binding term sheet to amend and restate a license agreement originally effective September 24, 1997.
- Licensing Scope: S&P grants CME a license to use certain S&P stock indexes and related trademarks for futures and options contracts.
- Exclusivity Terms:
- General license is exclusive through December 31, 2016, and non-exclusive through December 31, 2017.
- S&P 500 Index license remains exclusive through December 31, 2008. Exclusivity extends to December 31, 2016, contingent on meeting minimum average trading volume or paying an additional fee.
- New products listed after the effective date receive an exclusive license for two to three years, subject to volume requirements thereafter.
- Right of First Refusal: CME retains the right of first refusal for new stock indexes developed by S&P during the agreement term.
- Termination Rights: S&P may terminate licenses for new indexes if CME fails to launch a product within one year (subject to regulatory delays). Licenses become non-exclusive if CME lists certain competitive products.
- Dispute Resolution: Both parties agreed not to restore litigation filed in August 2004 regarding the 1997 License Agreement, which was previously closed by the court on June 24, 2005.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the contractual terms. The primary contingency noted is the potential loss of exclusivity for the S&P 500 Index if minimum trading volume thresholds are not met, though CME retains the option to pay an additional fee to maintain exclusivity.
Key Facts for Investor Verification
- Confirmation of the specific per trade fee structure and its impact on CME's cost basis.
- Verification of current trading volumes for the S&P 500 Index to assess the risk of losing exclusivity after 2008.
- Review of the "certain competitive products" clause to understand triggers for non-exclusive status.
- Assessment of the strategic value of the right of first refusal for future S&P index developments.